FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

One-Day Inspection Pilot Underway at FDA

FDA launches a pilot program using one-day inspectional assessments as part of a broader effort to modernize its oversight model and deploy inspection...

latest-news-card-1
Human Drugs

Makary Touts Hiring Push, Clinical Trial Reforms at FDLI

FDA commissioner Marty Makary says the agency is undertaking a major hiring push and a series of operational reforms aimed at strengthening its scient...

latest-news-card-1
Human Drugs

FDA Releases Bio-Thera Solutions FDA-483

FDA releases the form FDA-483 with six observations from an inspection at Chinas Bio-Thera Solutions.

latest-news-card-1
Human Drugs

Commissioners National Priority Voucher for Bizengri

FDA awards Partner Therapeutics a Commissioners National Priority Voucher for a new Bizengri indication.

latest-news-card-1
Human Drugs

Guidance on CMC Flexibility for Human CGTs

FDA publishes a guidance explaining how the agency uses a flexible chemistry, manufacturing, and controls approach to help expedite the development, r...

latest-news-card-1
Human Drugs

FDA Meeting on AI pilot for Early-Stage Clinical Trials

FDA hosts a virtual public meeting later this month to address industry questions tied to a planned pilot program exploring the use of artificial inte...

latest-news-card-1
Medical Devices

Unetixs Vascular Selling Illegal Devices: FDA

FDA warns Unetixs Vascular about illegally marketing adulterated and misbranded vascular diagnostic ultrasound devices.

latest-news-card-1
Human Drugs

FDA Stresses Sponsor Responsibility in Decentralized Clinical Trials

FDA reaffirms support for decentralized clinical trials (DCTs) while making clear that moving trial activities outside traditional research sites does...

latest-news-card-1
Human Drugs

Makary Defends FDA Drug Decisions

FDA commissioner Marty Makary forcefully defends the agency against mounting criticism of recent drug rejections, arguing the agency is following the ...

latest-news-card-1
Human Drugs

CareFusion Hit With Warning at Texas Drug Facility

FDA sends a Warning Letter to CareFusion, citing widespread and repeat violations of current good manufacturing practice regulations at a Texas facili...